Grants
Additional funding opportunities
Research Funding Opportunities
Grants Awarded for Health Sciences Research
| Title | Type | $ Amount | Activity | Investigator | Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| Quantitative Assessment of Microbial Transmission in a Hotel Setting | Contract | $190,945.00 | Research | Kelly Reynolds | ESRAC | Reckitt Benckiser | 03/2022 |
| Pilot Grant Application - Use of Mass Cytometry, (CyTOF) to Evaluate Type 2 Biomarkers in Nasal Lavage | Grant | $21,886.00 | Research | Monica Kraft | Asthma/Airway Disease Rsch Ctr | American Lung Association | 03/2022 |
| NIH RECOVER: A Multi-site Observational Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults (Initiative: RESEARCHING COVID TO ENHANCE RECOVERY (RECOVER) INITIATIVE) | Contract | $2,994,492.00 | Research | Janko Nikolich-Zugich | AEGIS Consortium | NYU Grossman School of Medicine | 03/2022 |
| Lead Principal Investigator Agreement | Contract | $26,250.00 | Research | Cori Daines | Asthma/Airway Disease Rsch Ctr | Vertex Pharmaceuticals, Incorporated | 03/2022 |
| IPA for Chase Irwin | Contract | $64,549.00 | Research | Christopher Glembotski | COM Phx Campus Administration | United States Department of Veterans Affairs | 03/2022 |
| IPA Agreement for Marco Tavera-Garcia | Contract | $43,673.00 | Research | Marco Tavera-Garcia | Immunobiology | United States Department of Veterans Affairs | 03/2022 |
| High Fidelity Patient Simulator Studies of Carbon Dioxide (CO2) Accumulation and Physiological Effects of Superhydrophilic Nanoparticle Material (CAMO = cysteic acid mineral oxide) in CAMO-treated Mas | Contract | $394,497.00 | Research | Esther Sternberg | Andrew Weil Ctr Intgrtv Med | Arizona Commerce Authority | 03/2022 |
| Development of PAR-2 Small Molecule Antagonists for the Treatment of Asthma | Grant | $153,827.00 | Research | Scott Boitano | Asthma/Airway Disease Rsch Ctr | PARmedics Inc | 03/2022 |
| Coronary Microvascular Disease in Diabetes: Role of NAMPT | Contract | $140,372.00 | Research | Joe Garcia | Medicine | University of California, San Diego | 03/2022 |
| Clinical Decision Support System Initiate: Precision Medicine through Pharmacogenomics and Decision Support | Grant | $1,500,000.00 | Research | Craig Heise | COM Phx Internal Medicine | Flinn Foundation | 03/2022 |
| Biomarker Development for the Evaluation of Mas Agonist, RASRx1902, in Amyotrophic Lateral Sclerosis | Grant | $1,521,025.00 | Research | Kathleen Rodgers | UAHS Brain Science | United States Army Medical Research Acquisition Activity | 03/2022 |
| 3/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact | Grant | $159,424.00 | Research | Ayman Fanous | COM Phx Psychiatry | Icahn School of Medicine at Mount Sinai | 03/2022 |
| (LTW) Novel Therapeutic Delivery System for Pediatric IBD | Grant | $130,000.00 | Research | Fayez Ghishan | Pediatrics | Crohn's and Colitis Foundation of America | 03/2022 |
| Integrative Psychiatry Curriculum Expansion | Grant | $114,460.00 | Instruction | Noshene Ranjbar | Psychiatry | University of Arizona Foundation | 03/2022 |
| Integrative Hematology Oncology Training Program | Grant | $90,000.00 | Instruction | Krisstina Gowin | Medicine | The Weil Foundation | 03/2022 |
| Work Order to the Master Subaward Agreement for Non-Industry Funding Sources between Public Health Institute, Contracting on behalf of The Children's Oncology Group | Contract | $750,000.00 | Clinical Trial | Holly Pariury | Cancer Center Division | Public Health Institute | 03/2022 |
| Work Order to the Master Subaward Agreement for Non-Industry Funding Sources between Public Health Institute (PHI) Contracting on behalf of the Children's Oncology Group (COG) | Contract | $750,000.00 | Clinical Trial | Holly Pariury | Cancer Center Division | Public Health Institute | 03/2022 |
| Treating Obstructive Sleep APnea using TaRgetEd HYpoglossal Neurostimulation | Contract | $396,563.20 | Clinical Trial | Saif Mashaqi | Medicine | LivaNova | 03/2022 |
| Prospective tReatment EffiCacy in IPF uSIng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study | Contract | $460,066.00 | Clinical Trial | Sachin Chaudhary | Medicine | University of Michigan | 03/2022 |
| Prospective Clinical and Imaging Outcomes of Acute Pulmonary Embolism Following Catheter Directed Aspiration Thrombectomy Versus Conservative Therapy Alone: a Pilot Study | Contract | $153,562.52 | Clinical Trial | Gregory Woodhead | Medical Imaging | Inari Medical | 03/2022 |
| Phase 2, Prospective, Single Arm Medical Food Study to Evaluate a Standardized Nonessential Amino Acid Restriction (NEAAR) Medical Food for the Dietary Management of Metastatic Pancreatic Cancer | Contract | $227,886.12 | Clinical Trial | Rachna Shroff | Cancer Center Division | Faeth Therapeutics, Inc. | 03/2022 |
| Member Institution Purchased Service Agreement with NRG Oncology Foundation for Institution's participation in the conduct of certain oncology clinical trials (the "NRG Agreement") | Contract | $215,025.00 | Clinical Trial | Baldassarre Stea | Cancer Center Division | NRG Oncology | 03/2022 |
| First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment - the RAAFT-3 Trial | Contract | $116,445.00 | Clinical Trial | Mathew Hutchinson | Sarver Heart Center | University of Pennsylvania | 03/2022 |
| A Randomized, Double-Blind, Dose-Ranging, Placebo-Controlled Phase 2a Evaluation of the Safety, Tolerability and Pharmacokinetics of PLN-74809 in Participants with Idiopathic Pulmonary Fibrosis (IPF) | Contract | $253,941.38 | Clinical Trial | Sachin Chaudhary | Medicine | Pliant Therapeutics, Inc. | 03/2022 |
| A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for F508del or Heterozygous f | Contract | $577,503.72 | Clinical Trial | Cori Daines | Asthma/Airway Disease Rsch Ctr | Vertex Pharmaceuticals, Incorporated | 03/2022 |